• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

婴儿肝血管瘤:回顾与展望

Infantile hepatic hemangiomas: looking backwards and forwards.

作者信息

Gong Xue, Li Yanan, Yang Kaiying, Chen Siyuan, Ji Yi

机构信息

Division of Oncology, Department of Pediatric Surgery, West China Hospital of Sichuan University, Chengdu 610041, China.

Pediatric Intensive Care Unit, Department of Critical Care Medicine, West China Hospital of Sichuan University, Chengdu 610041, China.

出版信息

Precis Clin Med. 2022 Feb 11;5(1):pbac006. doi: 10.1093/pcmedi/pbac006. eCollection 2022 Mar.

DOI:10.1093/pcmedi/pbac006
PMID:35692445
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8982613/
Abstract

Infantile hepatic hemangiomas (IHHs) are common benign tumors seen in the liver of infants. IHHs are true infantile hemangiomas (IHs) and have phases of proliferation and involution parallel to those of cutaneous IHs. The definition and classification of IHH are still confusing in the literature. The mechanisms during the pathogenesis of IHH have yet to be discovered. The clinical manifestations of IHH are heterogeneous. Although most IHH lesions are asymptomatic, some lesions can lead to severe complications, such as hypothyroidism, consumptive coagulopathy, and high-output congestive cardiac failure. Consequently, some patients can possibly encounter a fatal clinical condition. The heterogeneity of the lesions and the occurrence of disease-related comorbidities can make the treatment of IHH challenging. Oral propranolol is emerging as an effective systemic approach to IHH with obvious responses in tumor remission and symptom regression. However, the precise clinical characteristics and treatment strategies for patients with severe IHH have not yet been well established. Here, we summarize the epidemiology, pathogenic mechanism, clinical manifestations, diagnosis, and treatment of IHH. Recent updates and future perspectives for IHH will also be elaborated.

摘要

婴儿肝血管瘤(IHHs)是婴儿肝脏中常见的良性肿瘤。IHHs是真正的婴儿血管瘤(IHs),具有与皮肤IHs相似的增殖期和消退期。IHH的定义和分类在文献中仍存在混淆。IHH发病机制中的相关机制尚未被发现。IHH的临床表现具有异质性。虽然大多数IHH病变无症状,但一些病变可导致严重并发症,如甲状腺功能减退、消耗性凝血病和高输出量充血性心力衰竭。因此,一些患者可能会面临致命的临床状况。病变的异质性和疾病相关合并症的发生会使IHH的治疗具有挑战性。口服普萘洛尔正在成为一种有效的全身性治疗IHH的方法,在肿瘤消退和症状缓解方面有明显效果。然而,重度IHH患者的确切临床特征和治疗策略尚未完全确立。在此,我们总结了IHH的流行病学、致病机制、临床表现、诊断和治疗。还将阐述IHH的最新进展和未来展望。

相似文献

1
Infantile hepatic hemangiomas: looking backwards and forwards.婴儿肝血管瘤:回顾与展望
Precis Clin Med. 2022 Feb 11;5(1):pbac006. doi: 10.1093/pcmedi/pbac006. eCollection 2022 Mar.
2
Resolution of Consumptive Hypothyroidism Secondary to Infantile Hepatic Hemangiomatosis with a Combination of Propranolol and Levothyroxine.普萘洛尔与左甲状腺素联合治疗婴儿肝血管瘤病继发的消耗性甲状腺功能减退症的疗效
J Clin Res Pediatr Endocrinol. 2018 Jul 31;10(3):294-298. doi: 10.4274/jcrpe.4865. Epub 2018 Feb 28.
3
Multifocal Infantile Hepatic Hemangiomas Complicated by Consumptive Hypothyroidism: The Benefits of Early Diagnosis and Treatment.多灶性婴儿肝血管瘤合并消耗性甲状腺功能减退症:早期诊断和治疗的益处
J Pediatr Hematol Oncol. 2023 Mar 1;45(2):e294-e297. doi: 10.1097/MPH.0000000000002509. Epub 2022 Jul 26.
4
Combination therapy of propranolol, levothyroxine, and liothyronine was effective in a case of severe consumptive hypothyroidism associated with infantile hepatic hemangioma.普萘洛尔、左甲状腺素和碘塞罗宁联合治疗对一例与婴儿肝血管瘤相关的严重消耗性甲状腺功能减退症有效。
Clin Pediatr Endocrinol. 2019;28(1):9-14. doi: 10.1297/cpe.28.9. Epub 2019 Jan 31.
5
Screening for infantile hepatic hemangioma in patients with cutaneous infantile hemangioma: A multicenter prospective study.筛查皮肤婴幼儿血管瘤患儿中的肝婴幼儿血管瘤:一项多中心前瞻性研究。
J Am Acad Dermatol. 2021 May;84(5):1378-1384. doi: 10.1016/j.jaad.2020.11.062. Epub 2020 Dec 4.
6
History of the infantile hepatic hemangioma: From imaging to generating a differential diagnosis.婴儿肝血管瘤的病史:从影像学检查到鉴别诊断
World J Clin Pediatr. 2016 Aug 8;5(3):273-80. doi: 10.5409/wjcp.v5.i3.273.
7
Infantile hepatic hemangiomas associated with high-output cardiac failure and pulmonary hypertension.与高输出量心力衰竭和肺动脉高压相关的婴儿肝血管瘤
BMC Cardiovasc Disord. 2019 Oct 11;19(1):216. doi: 10.1186/s12872-019-1200-6.
8
Clinical experience of infantile hepatic hemangioma.婴儿肝血管瘤的临床经验
J Formos Med Assoc. 2025 May;124(5):446-451. doi: 10.1016/j.jfma.2024.05.017. Epub 2024 Jun 12.
9
Multiple cutaneous and hepatic infantile hemangiomas having a successful response to propranolol as monotherapy at neonatal period.新生儿期单药普萘洛尔治疗成功的多发性皮肤和肝脏婴儿血管瘤。
G Ital Dermatol Venereol. 2013 Oct;148(5):525-30.
10
Consumptive Hypothyroidism Due to Diffuse Hepatic Hemangiomas Treated With Propranolol Therapy.普萘洛尔治疗弥漫性肝血管瘤所致消耗性甲状腺功能减退症。
Indian Pediatr. 2020 Apr 15;57(4):366-368.

引用本文的文献

1
A new type of congenital hepatic hemangioma - rapid postnatal proliferation followed by regression.一种新型先天性肝血管瘤——出生后迅速增殖随后消退。
Front Oncol. 2025 Jul 2;15:1508461. doi: 10.3389/fonc.2025.1508461. eCollection 2025.
2
PHACE syndrome: looking backward and forward.PHACE综合征:回顾与展望。
Orphanet J Rare Dis. 2025 Jul 7;20(1):345. doi: 10.1186/s13023-025-03899-7.
3
Real-life efficacy and safety of oral propranolol for ocular adnexal infantile hemangiomas: observational cohort study.口服普萘洛尔治疗儿童眼眶附件血管瘤的实际疗效和安全性:观察性队列研究

本文引用的文献

1
Noninferiority and Safety of Nadolol vs Propranolol in Infants With Infantile Hemangioma: A Randomized Clinical Trial.纳多洛尔与普萘洛尔治疗婴儿血管瘤的非劣效性和安全性:一项随机临床试验。
JAMA Pediatr. 2022 Jan 1;176(1):34-41. doi: 10.1001/jamapediatrics.2021.4565.
2
Infantile Hemangiomas: An Update on Pathogenesis and Treatment.婴儿血管瘤:发病机制与治疗的最新进展
J Clin Med. 2021 Oct 9;10(20):4631. doi: 10.3390/jcm10204631.
3
Clinical features and management of kaposiform hemangioendothelioma and tufted angioma: Similarities and differences.
Front Ophthalmol (Lausanne). 2025 May 5;5:1493171. doi: 10.3389/fopht.2025.1493171. eCollection 2025.
4
A report of 12 cases of congenital hepatic hemangioma and literature review.12例先天性肝血管瘤报告及文献复习
Front Pediatr. 2025 Apr 28;13:1453019. doi: 10.3389/fped.2025.1453019. eCollection 2025.
5
Complete regression of a huge fetal hepatic hemangioma with cardiac complication after atrioventricular septal repair: a case description and literature analysis.房室间隔修复术后巨大胎儿肝脏血管瘤伴心脏并发症完全消退:病例描述与文献分析
Quant Imaging Med Surg. 2025 Apr 1;15(4):3713-3722. doi: 10.21037/qims-24-444. Epub 2025 Mar 26.
6
Clinical characteristics and managements of congenital hepatic hemangioma: a cohort study of 211 cases.先天性肝血管瘤的临床特征与管理:一项211例病例的队列研究
Hepatol Int. 2025 Jun;19(3):682-691. doi: 10.1007/s12072-024-10756-5. Epub 2024 Nov 29.
7
Targeting ESM1 via SOX4 promotes the progression of infantile hemangioma through the PI3K/AKT signaling pathway.通过SOX4靶向ESM1可通过PI3K/AKT信号通路促进婴幼儿血管瘤的进展。
Precis Clin Med. 2024 Oct 9;7(4):pbae026. doi: 10.1093/pcmedi/pbae026. eCollection 2024 Dec.
8
Editorial: Recent advances in childhood vascular tumors.社论:儿童血管肿瘤的最新进展
Front Oncol. 2024 Jul 25;14:1465155. doi: 10.3389/fonc.2024.1465155. eCollection 2024.
9
Infantile hemangioma: the common and enigmatic vascular tumor.婴儿血管瘤:常见且神秘的血管肿瘤。
J Clin Invest. 2024 Apr 15;134(8):e172836. doi: 10.1172/JCI172836.
10
Coexistence of kaposiform hemangioendothelioma and capillary malformation: More than a coincidence? Two case reports.卡波西样血管内皮瘤与毛细血管畸形并存:仅是巧合?两例病例报告。
Heliyon. 2024 Mar 29;10(7):e28802. doi: 10.1016/j.heliyon.2024.e28802. eCollection 2024 Apr 15.
卡波西样血管内皮瘤和簇状血管瘤的临床特征与管理:异同点
J Am Acad Dermatol. 2022 Jul;87(1):172-174. doi: 10.1016/j.jaad.2021.07.012. Epub 2021 Jul 14.
4
Infantile Hepatic Hemangiomas.婴儿期肝血管瘤
N Engl J Med. 2021 Jul 15;385(3):e10. doi: 10.1056/NEJMicm1907892.
5
Infantile Hemangioma and the Risk Factors in a Japanese Population: A Nationwide Longitudinal Study-The Japan Environment and Children's Study.日本人群中婴儿血管瘤及其危险因素:一项全国性纵向研究——日本环境与儿童研究
J Invest Dermatol. 2021 Nov;141(11):2745-2748.e2. doi: 10.1016/j.jid.2021.05.011. Epub 2021 Jun 8.
6
Efficacy and Safety of Propranolol vs Atenolol in Infants With Problematic Infantile Hemangiomas: A Randomized Clinical Trial.普萘洛尔对比阿替洛尔治疗婴幼儿血管瘤疗效及安全性的随机临床试验
JAMA Otolaryngol Head Neck Surg. 2021 Jul 1;147(7):599-607. doi: 10.1001/jamaoto.2021.0454.
7
Metastatic neuroblastoma masquerading as infantile hemangioma in a 4-month-old child.4 月龄婴儿,神经母细胞瘤转移伪装为婴儿血管瘤。
Pediatr Blood Cancer. 2021 May;68(5):e28920. doi: 10.1002/pbc.28920. Epub 2021 Feb 28.
8
Critical role of Aquaporin-1 and telocytes in infantile hemangioma response to propranolol beta blockade.水通道蛋白-1 和间质细胞在普萘洛尔β阻断治疗婴儿血管瘤反应中的关键作用。
Proc Natl Acad Sci U S A. 2021 Feb 16;118(7). doi: 10.1073/pnas.2018690118.
9
Microarray expression profile of mRNAs and long noncoding RNAs and the potential role of PFK-1 in infantile hemangioma.婴儿血管瘤中mRNA和长链非编码RNA的微阵列表达谱及磷酸果糖激酶-1的潜在作用
Cell Div. 2021 Jan 11;16(1):1. doi: 10.1186/s13008-020-00069-y.
10
NOGOB receptor-mediated RAS signaling pathway is a target for suppressing proliferating hemangioma.NOGOB 受体介导的 RAS 信号通路是抑制增殖性血管瘤的靶点。
JCI Insight. 2021 Feb 8;6(3):142299. doi: 10.1172/jci.insight.142299.